Home Your basket
• Airbag and hearing loss: ...
   Price 8.50 €
• A survey of current wound...
   Price 5.50 €
• Modern lipostructure: The...
   Price 10.50 €
• Transit time of swallowin...
   Price 10.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Mycobacterial cervical ly...
   Price 10.50 €
• Middle ear adenoma / carc...
   Price 8.50 €
• Post-traumatic otoscleros...
   Price 8.50 €
• From the physiologic perf...
   Price 14.00 €
• The frontal pneumosinus d...
   Price 8.50 €
• Art and nose....
   Price 8.50 €
• Bronchogenic cyst of the ...
   Price 10.50 €
• Adenoid cystic carcinoma ...
   Price 5.50 €
• Association of thyroid he...
   Price 12.50 €
• Facial nerve outcome af...
   Price 12.50 €
• Thyroid surgery (356 case...
   Price 10.50 €
• The monaural pseudo-stere...
   Price 8.50 €
• Multi-factorial analysis ...
   Price 10.50 €
• Results of fine needle as...
   Price 10.50 €
• Comparative results of ty...
   Price 10.50 €
• Focus on the BPPV: Semont...
   Price 12.50 €
• «Mini-rhinoplasty»...
   Price 10.50 €
• A case of nasal NK/T cell...
   Price 5.50 €
• Evaluation of the use of ...
   Price 8.50 €
• Atelectasis of the maxill...
   Price 8.50 €
• Diagnostic value of fine-...
   Price 8.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Adenomatoid hamartoma of ...
   Price 5.50 €
• Otoplasty for prominent e...
   Price 8.50 €
• Hyperglycemia after intra...
   Price 8.50 €
• Prosodic analysis of spee...
   Price 10.50 €
• Diagnosis of submandibula...
   Price 10.50 €
• Idiopathic sudden deafnes...
   Price 10.50 €
• Spontaneous cerebrospinal...
   Price 8.50 €

Total Order 315.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 4 - 2001 o

RHINOLOGY

Mucosal melanomas of the head and neck. Experience of the Salah Azaiz Institute (Tunis).


Authors : Z. Oueslati, S. Touati, S. Gritli, A. El-May, F. Benna, H. Boussen, A. El-Khedim, M. Ferjaoui, A. Ladgham (Tunis)

Ref. : Rev Laryngol Otol Rhinol. 2001;122,4:237-240.

Article published in french
Downloadable PDF document french



Summary : The mucosal melanoma of the head and neck is rare and of late diagnosis. This retrospective study concerns 17 cases brought together in 30 years. Sex-ratio was of 1,1, the average age of 58 years. Tumoral seats were the following ones : nasal cavity and paranasal sinus (n=10), nasopharyngeal cavity (n=2), gingival seat (n=2), palate (n=1), laryngeal seat (n=1), middle ear (n=1). Tumoral extension was classified an follows: stage I: 52,9%, stage II: 17,6%, stage III: 29,4%. Melanomas were achromic in 23,5% of cases. On the therapeutic plan, 47,1% of the patients were treated in a purpose palliative because of the importance of the tumoral extension. Seven patients (41,2%) were treated surgically ; three among them received an additional radiotherapy for an insufficient tumoral excision or adenopathy in break capsular. Two patients (11,8%) were treated by exclusive radiotherapy. The rates of survival were 17,6% in 2 years, and 5,9% in 5 years. The average duration of survival was of 18,1 months. The causes of failure were essentially local and metastatic.

Price : 8.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE